The Validity of The Patient Health Questionnaire-2 As A Depression Screening Tool in Women Receiving Antenatal Care at Chelstone First Level Hospital, Lusaka, Zambia

The Validity of The Patient Health Questionnaire-2 As A Depression Screening Tool in Women Receiving Antenatal Care at Chelstone First Level Hospital, Lusaka, Zambia

Keywords: Major Depressive Disorder;, Psychometrics;, Receiver Operating Characteristic Curve Analysis;, Sensitivity, Specificity;, Area under the Curve;, Antenatal Care;, Patient Health Questionnaire-2

Abstract

Background: The Patient Health Questionnaire-2 is frequently used as the first step in assessing people for major depressive disorder symptoms. However, its accuracy in correctly distinguishing between major depressive disorder cases and non-cases among pregnant women seeking prenatal care services in Zambia has not been studied. We set out to determine the validity of The Patient Health Questionnaire-2 as a brief screening tool for antenatal depression in pregnant women attending antenatal care services at Chelstone First Level Hospital in Lusaka, using the Edinburgh Postnatal Depression Scale as the gold standard. Method: We carried out a descriptive cross-sectional study and enrolled pregnant women who were receiving prenatal treatment at Chelstone First Level Hospital. The Patient Health Questionnaire -2 was used to screen 281 pregnant women, with the Edinburgh Postnatal Depression Scale (EPDS) serving as the gold standard. The Patient Health Questionnaire -2's concurrent validity was determined by comparing its performance in distinguishing between major depressive disorder cases and non-cases with the Edinburgh Postnatal Depression Scale, which served as the gold standard. Results: On receiver operating characteristic curve analysis, the Patient Health Questionnaire-2 predicted major depressive disorders with 66 percent sensitivity and 89 percent specificity at a cut-off score of 2, with an area under the curve (AUC) of 0.90 [95 percent CI: 0.85-0.94]. For identifying major depressive illness in pregnancy, a cut-off value of 2 was shown to be best for optimizing sensitivity without sacrificing specificity. Women with a PHQ-2 score of 2 had substantially higher Edinburgh Postnatal Depression Scale ratings for depressive symptoms than women with a score less than 2. The PHQ-2 had a positive and negative predictive value of 0.75 and 0.83, respectively. Conclusion: The PHQ-2 is a reliable screening tool for major depression in pregnant women seeking prenatal healthcare in primary care. To confirm the diagnosis, it should be followed by a more comprehensive diagnostic process involving structured clinical interviews or longer diagnostic tools such as the Structured Clinical Interview for DSM Disorders.
Published
2022-03-13